CALA (Calithera Biosciences) Research & Development: $28.53 Mil (TTM As of Dec. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Calithera Biosciences Research & Development?

Calithera Biosciences CALA Research & Development is $28.53 Mil as of Dec. 2022.

Research & Development is the aggregate amount of research and development expenses during the year. Calithera Biosciences's Research & Development for the three months ended in Dec. 2022 was $4.76 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2022 was $28.53 Mil.

Calithera Biosciences  (OTCPK:CALA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Calithera Biosciences Research & Development Related Terms

Calithera Biosciences Research & Development Historical Data

* Premium members only.

The historical data trend for Calithera Biosciences's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Calithera Biosciences Research & Development Chart

Calithera Biosciences Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 66.20 76.29 71.02 53.46 28.53

Calithera Biosciences Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.74 9.57 7.76 6.45 4.76

Calithera Biosciences Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $28.53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $28.53 Mil mean?
Calithera Biosciences (CALA) has a Research & Development of $28.53 Mil as of Dec. 2022. Research and development expense is the total cost for research and development activities. View historical data on Calithera Biosciences and its competitors.
Is Calithera Biosciences' Research & Development too high?
Calithera Biosciences' current Research & Development is $28.53 Mil.
How does Calithera Biosciences' Research & Development compare to PPCB and QBIO?
Calithera Biosciences' Research & Development of $28.53 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Diversified Financial Services company?
A good Research & Development depends on the Diversified Financial Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Calithera Biosciences and its competitors. Calithera Biosciences's current Research & Development is $28.53 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Calithera Biosciences stock overvalued right now?
Calithera Biosciences (CALA) has a current Research & Development of $28.53 Mil. The current Research & Development is $28.53 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Calithera Biosciences (CALA), the current Research & Development is $28.53 Mil as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Calithera Biosciences Business Description

Address 343 Oyster Point Boulevard, Suite 200, South San Francisco, CA, USA, 94080
Calithera Biosciences Inc is a shell company.